Codexis Q1 revenue drops to $7.5M from $17.1M; net loss widens to $20.7M

CODEXIS, INC.

2025-Q1 EPS reported -$0.25 revenue$7,543,000

Revenue $7.5M vs $17.1M in Q1 2024; decline due to $6M one-time Roche license and large orders in prior year.
Net loss $20.7M ($0.25/share) vs $11.5M ($0.16/share) in Q1 2024; R&D expenses up to $12.9M.
Cash $59.8M; expects to fund operations through positive cash flow by end 2026.
Reiterates FY 2025 revenue guidance of $64M-$68M; secured first revenue contract for ECO Synthesis manufacturing.
Appointed Christos Richards and Cynthia Collins to board; Arthur Levin to Strategic Advisory Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.